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Abstract
Aim: The prolongation of T-wave-peak-to-end interval (Tpe) and arrhythmogenic index (AIX) could predict arrhythmias. Developing of ventricular arrhythmias is 
increased during hemodialysis (HD), but the effects of hemodiafiltration (HDF) on ventricular repolarization have not been elucidated yet.
Methods: Thirty patients was investigated while they were receiving hemodiafiltration over a period of three months then the same group of patients was evaluated 
during treatment with hemodialysis for at least another three months. Ionic parameters, surface electrocardiograms (ECG), echocardiography, Holter ECGs were 
performed.
Results: T-wave-peak-to-end interval and arrhythmogenic index significantly increased at the 240th minute of hemodialysis while did not change during 
hemodiafiltration. No malignant ventricular arrhythmias occurred, but number of ventricular premature beats was significantly higher during hemodialysis as 
compared to those during hemodiafiltration. Regarding hemodialysis a significant relationship was observed between the ratio of ventricular premature beats and 
arrhythmogenic index. Left ventricular mass index, septal-, posterior wall, inferior vena cava, left atrial diameters showed a positive correlation with T-wave-peak-
to-end interval only in the case of hemodialysis. A negative correlation occurred between the left ventricular ejection fraction, T-wave-peak-to-end interval and 
arrhythmogenic index, moreover between serum sodium and T-wave-peak-to-end interval, arrhythmogenic index during hemodialysis.
Conclusions: Our results suggest that hemodialysis has unfavourable effect on the studied ECG parameters compared to hemodiafiltration.
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Introduction
Several studies have shown the increased susceptibility of 
developing ventricular arrhythmias during hemodialysis [1-3]. 
Cardiovascular mortality of patients on chronic hemodialysis accounts 
for more than 50% of the total mortality rate, and its frequency is 
17 times higher when compared to the healthy population [4]. The 
incidence of ventricular arrhythmias leading to sudden cardiac death 
in patients on chronic hemodialysis program is approximately 1.4% to 
25% [5,6]. Multiple factors account for the genesis of arrhythmias that 
include increased wall stress of the myocardium, altered catecholamine 
and baroreceptor sensitivity, ischaemic heart disease, uraemia, renal 
anaemia, hypertension, hyperlipidaemia, acidosis, and ionic imbalance 
[2,7]. Whereas hemodialysis eliminates small molecular weight uremic 
toxins by diffusion, hemodiafiltration eliminates higher molecular 
weight toxic polypeptides (characterized by β-2 microglobulin) by 
convective transport. In comparison to hemodialysis, the quality of life 
is superior and mortality rates are lower in the case of hemodiafiltration 
[8-12]. It is not cleared to what extent the changes in arrhythmogeneity 
are responsible for the observed beneficial clinical results. Previously, 
the prolongation of the QT and corrected QT interval (QTc), as 
measured on a surface ECG, has been shown to predict malignant 
ventricular arrhythmias and sudden cardiac death, also QT dispersion 
(QTd) was accepted to determine cardiac arrhythmogeneity [13-15]. 
A novel electrocardiographic marker, T-wave-peak-to-end interval has 
been reported to represent the transmural dispersion of repolarization 
of the left ventricle and the vulnerability to ventricular arrhythmias 
[16-18]. The prolongation of T-wave-peak-to-end interval has been 
proved to be associated with increased mortality rates in long QT 
syndrome, acute myocardial infraction, sleep apnoea [19,20] and 
hypertrophic cardiomyopathy [21]. Furthermore, the Tpe/QT ratio is 
used as an arrhythmogenic index of ventricular arrhythmogenesis [22]. 
It has been demonstrated that in patients with acquired QT syndrome 
the AIX is superior to QT interval and QT dispersion in the prediction 
of torsades de pointes ventricular tachycardia. Also, arrhythmogenic 
index was shown to be a valuable predictor of sudden cardiac death 
[21,23,24]. Throughout our work, we aimed to determine what effects 
hemodialysis and hemodiafiltration would have on T-wave-peak-to-
end interval and AIX reflecting ventricular arrhythmogeneity.
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made with a magnifying factor of three. Three T-wave-peak-to-
end interval and QT intervals were measured with callipers by one 
examiner in a blinded fashion in lead V6. QT interval was measured 
from the first electrical activity to the offset at the junction between the 
end of T wave deflection and the isoelectric line. The T-wave-peak-to-
end interval was defined as the time between the highest point of the 
T wave and the intersection of the isoelectric line and the downslope 
of T wave. T-wave-peak-to-end interval was calculated as the average 
of the three T-wave-peak-to-end interval. Arrhythmogenic index was 
defined as the ratio of T-wave-peak-to-end interval and QT, where 
QT was defined as the longest of the three QT intervals measured in 
lead V6. Before and after the renal replacement therapy transthoracic 
echocardiography investigations (M-mode, 2 D) were carried out with 
a pulsed, and a continuous wave and tissue Doppler technique (Philips 
ATL HDI 5000 imaging system with a 3.5 MHz transducer). During 
the examinations the left atrium’s cross diameter was measured from 
the parasternal long-axis view, then, based on an apical four-chamber 
view, the Simpson’s method was used to determine the left ventricular 
ejection fraction (EF). Using the Devereux-Reichek formula the left 
ventricular mass index was calculated ({1.04 x [(end-diastolic diameter 
of the left ventricle + interventricular septum thickness + the posterior 
wall thickness of the left ventricle)3-end-diastolic diameter of the left 
ventricle3] -14}/height). The diameter of the inferior vena cava was 
measured from the subcostal view. Holter-ECGs (GE Medical SEER 
Light) were performed, where monitoring was started before the 
therapy and ended 24 hours afterwards. The number of ventricular 
premature beats was compared to the total number of beats and the 
resulting modulus was used to eliminate the variations arising from the 
short differences between the duration of the examinations. Statistical 
analyses were carried out with the help of SAS 8.2 for Windows. The 
variations of the investigated parameters over time and the differences 
between the two modalities were investigated by using analysis of 
variance (ANOVA). The correlations between the parameters were 
analysed by using the Pearson’s test when the distribution was normal 
and by Spearman’s rank test in the case of an abnormal distribution. 
Throughout the analysis the p <0.05 probability level was considered to 
be statistically significant. Data are presented as mean ± SD.
Results
In the case of conventional hemodialysis T-wave-peak-to-end 
interval was found to be higher even at the beginning of the treatment 
compared to hemodiafiltration, although this difference did not reach 
a significant level. Furthermore, this tendency was detected during 
the whole period of the sessions. In the case of hemodialysis T-wave-
peak-to-end interval increased at the 240th minute compared to the 
starting level (135.32 ± 29.08 msec vs. 102.64 ± 22.16 msec, p<0.001) 
and decreased 2 hours after completion of treatment (Figure 1). Similar 
significant changes were not present during hemodiafiltration. The 
arrhythmogenic index was found to increase constantly in the case 
of hemodialysis, and a significant lengthening appeared at the 240th 
minute compared to the baseline (0.26 ± 0.052 vs. 0.33 ± 0.08 p=0.004), 
while it showed a decrease two hours after finishing the treatment 
(Figure 2). During hemodiafiltration such significant changes were 
not explored. Left ventricular mass index developed to be in a positive 
correlation with T-wave-peak-to-end interval only in the case of 
hemodialysis (r=0.53, p=0.010), but non-significant positive tendency 
appeared regarding hemodiafiltration, too (r=0.13, p=0.479) (Figure 
3). Both septal (r=0.48 p=0.002) and posterior wall (r=0.45, p=0.005) 
diameters showed a positive correlation with T-wave-peak-to-end 
interval only in the case of hemodialysis. Furthermore, left ventricular 
ejection fraction proved to correlate negatively with T-wave-peak-to-
Methods
Our study population consisted of thirty patients (18 males, 12 
females, mean age 60.57 ± 13.62 years, range 23-85 years). Firstly, 
we collected and analysed the data of the patients while they were 
under hemodiafiltration over a period of three months and then the 
same patients were treated with conventional hemodialysis for at 
least another three months. This was followed, at the time of a regular 
hemodialysis, by another data collection. Patients were included who 
were suffering from end stage kidney disease (Stage 5) participating in 
regular hemodialysis program in our centre, and were willing to give 
their informed consent to take part in the study. Diseases that may 
affect cardiac pulse generation and conduction were exclusion criteria. 
Thus, subjects suffering from amyloidosis, sarcoidosis, carcinoid, 
hemochromatosis, diabetes mellitus or Parkinson’s disease were not 
involved in our study, furthermore, none of the patients had any history 
of atrial fibrillation. The causes of chronic renal failure in this patient 
population were the following: chronic glomerulonephritis (n=5), 
hypertensive and vascular nephropathy (n=12), chronic pyelonephritis 
(n=1), polycystic kidney disease (n=2), analgesic nephropathy (n=3), 
renal agenesis (n=1), lupus nephritis (n=2), and vasculitis (n=4). 
Clinical data of the study population are shown in Table 1. 
Twenty-one out of 30 patients took beta blockers during the 
examination period. Three patients were treated with carvedilol, 6 
patients with nebivolol and 12 patients took metoprolol during the 
study. All patients gave informed consent to participate in the study 
and the Institutional Ethics Committee on Human Research approved 
the study protocol. The hemodialysis and hemodiafiltration were 
performed three times a week in 4-hour long sessions with Fresenius 
4008 S and H machines (Fresenius Medical Care, Bad Homburg, 
Germany), and with Fx60 and Fx80 high-flux polysulfone dialyzers 
(Fresenius). During hemodiafiltration 15.16 ± 5 litres of ultrafiltrate 
was removed. The substitution fluid was prepared on-line from 
dialysis solution through a set of two membranes to purify it before 
infusing it directly into the blood line. The replacement solution was 
manufactured on-line from ultrapure water and consisted of 138 
mmol/L sodium, 2 or 3 mmol/L potassium (in 13 cases 2 mmol/l in 
17 cases 3 mmol/l), 1.5 mmol/L calcium, 0.5 mmol/L magnesium, 
and 1 g/L glucose. The blood flow was 338 ± 11.6 ml/min and did not 
differ significantly during the respective procedures (p<0.050). The 
bicarbonate buffered dialysis solution contained 138 mmol/L sodium, 
2 or 3 mmol/L potassium (the same as the substitution solution), 1.5 
mmol/L calcium, 0.5 mmol/L magnesium, and 1 g/L glucose. During 
the sessions no drugs other than isotonic sodium chloride and sodium 
heparin solutions were administered. The serum electrolyte levels were 
measured four times during the sessions and 2 hours afterwards. The 
arterial blood pressure was monitored non-invasively. ECGs were 
carried out five times in each case: at the beginning, in the 15th, 30th and 
the 240th  minutes, and finally two hours after the end of the sessions. 
ECGs were recorded at 25 mm/sec recording speed (Hewlett Packard 
Page Writer 200i) while the patients were in the supine position 
breathing freely, and were not talking. Copies of the recordings were 
Gender (male/female) 18/12 
Mean age (years) 60.57 ± 13.62 
Duration of renal replacement therapy (months) 93.13 ± 70.09 
Hypertension 27/30 (90%) 
Myocardial infarction 3/30 (10%) 
Ischemic heart disease 3/30 (10%) 
Hyperlipidemia 5/30 (16.7%) 
Table 1. Clinical characteristics of the studied population.
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end interval and arrhythmogenic index during both renal replacement 
modalities, but significant correlation appeared only in the case of 
hemodialysis (T-wave-peak-to-end interval: r= -0.4, p=0.028; AIX: r= 
-0.49, p=0.006) (Figure 4 and 5). Although the diameter of the inferior 
vena cava measured at the beginning of the sessions showed a positive 
relationship with T-wave-peak-to-end interval in both treatment 
modalities, significant coherence was shown to be present only in the 
case of conventional hemodialysis (r= 0.43, p=0.019) (Figure 6). Also, 
positive significant correlation between the decrease in inferior vena 
cava diameter and T-wave-peak-to-end interval was demonstrated 
only in the case of hemodialysis (r=0.48, p=0.007). Moreover, left atrial 
cross diameter measured at the beginning of the sessions and T-wave-
peak-to-end interval proved to correlate positively only in the case 
of hemodialysis (r=0.39, p=0.031) (Figure 7). A significant positive 
correlation between the decrease of left atrial cross diameter and T-wave-
peak-to-end interval was present only in the case of conventional 
hemodialysis (r=0.37, p=0.041). Total calcium and ionized calcium 
showed an increase, while the potassium, magnesium and phosphate 
levels were significantly decreased in both therapies and there were no 
significant differences between the two modalities (data not elaborated). 
While hemodiafiltration did not modulate sodium levels, hemodialysis 
was associated with a decrease observed in the 15th (p=0.330) and 30th 
minutes (p=0.570) compared to the baseline levels. Serum sodium 
measured at the beginning of hemodialysis sessions showed a negative 
correlation both with T-wave-peak-to-end interval (r= -0.4, p=0.029) 
and arrhythmogenic index (r= -0.47, p=0.010). At the end of treatment 
the serum glucose concentration was found to be significantly increased 
in both modalities (at the beginning of the hemodialysis: 5.69 ± 
1.16mmol/l; at the end: 6.81 ± 1.53 mmol/l, (p=0.008); at the beginning 
of the hemodiafiltration: 5.25 ± 0.72 mmol/l, at the end: 7.07 ± 1.58 
mmol/l, (p<0.0001) and it was persistently elevated two hours after 
the end of treatment. However, no significant correlation appeared 
between the studied ECG markers and glucose concentration. Changes 
in ventricular rate - characterized by the RR cycle length- increased 
Figure 1. Changes in T peak-end interval (Tpe) during hemodialysis and hemodiafiltration. 
T peak-end interval showed a significant lengthening at 240th minute only in the case of 
conventional hemodialysis. HD: hemodialysis, HDF: hemodiafiltration, * p < 0.05.
Figure 2. Changes in arrhythmogenic index (AIX) during hemodialysis and 
hemodiafiltration. A significant prolongation is shown at 240th minute of conventional 
hemodialysis, while no significant changes were observed in the case of hemodiafiltration. 
HD: hemodialysis, HDF: hemodiafiltration, * p<0.05.
Figure 3. The correlation between T peak-end interval (Tpe) and left ventricular mass index 
(LVMI). Significant positive correlation occurred only in the case of hemodialysis. HD: 
hemodialysis, HDF: hemodiafiltration, * p<0.05.
Figure 4. Left ventricular ejection fraction (EF) showed a significant negative correlation 
with T peak-end interval (Tpe) only in the case of hemodialysis. HD: hemodialysis, HDF: 
hemodiafiltration, * p<0.05.
Figure 5. A significant negative correlation was observed between arrhythmogenic index 
(AIX) and left ventricular ejection fraction (EF) only in the case of hemodialysis. HD: 
hemodialysis, HDF: hemodiafiltration, ** p<0.01.
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(from 798 ± 102.65 msec to 852±104.3 msec, p=0.005) at the 30th 
minute of hemodiafiltration, indicating a transient decrease of the 
heart frequency, and it then gradually decreased to the baseline after 
finishing the sessions. In the case of hemodialysis, the RR cycle length 
decreased significantly (800.6 ± 96.2 vs. 746.6 ± 125.5 msec, p=0.024) 
only 2 hours after treatment compared to the baseline. Regarding the 
blood pressure in both treatment modalities a rapid decrease occurred 
after the start of the sessions, which reached a significant level at the 
15th minute (HDF systolic p=0.0001; HDF diastolic p=0.046; HD 
systolic p=0.0004; HD diastolic p=0.006). The systolic blood pressure 
did not change significantly after this, however, the diastolic values 
continued to increase even after the end of treatment compared to 
the baseline (HDF p=0.21, HD p=0.73). During hemodiafiltration the 
systolic and diastolic values were higher even at the initial stages, but the 
difference proved not to be significant. At the beginning there were no 
significant differences in left atrial diameter between the two treatment 
modalities, however, by the end a significant decrease was observed in 
the case of hemodiafiltration (p=0.0002). In contrast, similar changes 
were not found during hemodialysis (p=0.120). Regarding ECG 
markers and blood pressure no relevant relationship was observed. 
During hemodialysis the average kT/V value (a ratio used to quantify 
hemodialysis treatment adequacy) was 1.35 ± 0.17, while it was found 
to be 1.39 ± 0.21 during hemodiafiltration. Nevertheless, with regard 
to kT/V values no significant differences were found between the two 
modalities (p=0.30). During the different therapies praedialytic serum 
bicarbonate values were also determined. However, regarding these 
parameters no significant differences were evaluated (HD: 19.6 ± 2.1 
vs. HDF: 20.7 ± 2.8; p=0.140). We adjusted the dialysate bicarbonate 
concentration individually in each cases in the range of 28-36 mmol/L 
aiming the plasma bicarbonate concentration of 20-22 mmol/L. 
Dialysate bicarbonate concentration was not changed during the study. 
Body weight and body mass index (BMI) decreased significantly in 
both modalities (the average BMI decrease in the case of hemodialysis: 
24.39 ± 4.19 kg/m2 vs. 23.59 ± 4.2 kg/m2 p=0.0002, in the case of 
hemodiafiltration: 24.37 ± 4.12 kg/m2 vs. 23.6 ± 4.14 kg/m2, p=0.0002), 
nevertheless no significant relationship was observed between BMI 
and the electrocardiographic parameters. Body weight of the patients 
decreased significantly in both therapies (hemodialysis: 67.47 ± 14.44 
kg vs. 65.3 ± 14.74 kg p=0.0001, hemodiafiltration: 67.4 ± 14.35 kg vs. 
65.29 ± 14.33 kg, p=0.0001). No malignant ventricular arrhythmias 
occurred, but the number of ventricular premature beats (recorded by 
24h-Holter ECG) was significantly higher during hemodialysis (HDF: 
183.1 ± 476.2 vs HD: 256.2 ± 656.9; p=0.018). Furthermore, the ratio of 
ventricular premature beats to the total number of heart beats differed 
significantly (p=0.019). A significant positive relationship appeared 
between the ratio of ventricular premature beats and arrhythmogenic 
index in the case of hemodialysis (r=0.37, p=0.04) (Figure 8). The left 
ventricular ejection fraction correlated negatively with the number of 
ventricular premature beats in both treatment modalities (HDF r=-
0.55, p=0.0015, HD r=-0.36, p=0.046). 
Discussion
The mortality rate of patients participating hemodiafiltration 
programs is 35% lower in comparison to patients on conventional 
hemodialysis programs [25,26]. It has been demonstrated, that in 
the case of hemodiafiltration the clearance of small- and medium- 
molecular weight substances is significantly higher compared to 
that of conventional hemodialysis [27-30]. By reducing the beta-
2 microglobulin concentration hemodiafiltration attenuates the 
incidence of amyloidosis by approximately 50% [31-35]. Furthermore, 
during hemodiafiltration oxidative stress is reduced and the lipid 
profile improves. Moreover, the suppression of inflammatory 
reactions may contribute to the positive changes in the frequency of 
Figure 6. Diameter of the inferior vena cava measured at the beginning of the sessions 
is shown to correlate significantly with T peak-end inteval (Tpe) only in the case of 
hemodialysis. HD: hemodialysis, HDF: hemodiafiltration, IVC: inferior vena cava, * 
p<0.05.
Figure 7. Left atrial cross diameter measured at the beginning of the renal replacement 
therapies showed a positive correlation with T peak-end interval (Tpe) in the case of 
hemodialysis. HD: hemodialysis, * p<0.05.
Figure 8. A significant positive relationship appeared between the ratio of ventricular 
premature beats and arrhythmogenic index in the case of hemodialysis. HD: hemodialysis, 
*p<0.05.
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anaemia [26,36]. Besides the numerous known factors, it might be 
also concluded that the patients receiving hemodiafiltration for their 
renal diseases were able to enjoy benefits resulting from the slower 
progression of the cardiac target organ damage as shown by Ohtake 
et al. [37]. In our present study we aimed to determine the changes 
of certain electrocardiographic markers during hemodiafiltration 
and conventional hemodialysis [38,39]. Previous studies have shown 
that T-wave-peak-to-end interval and AIX represent increased 
ventricular repolarization. Since altered dispersion of repolarization 
predisposes to ventricular arrhythmias and sudden cardiac death, these 
electrocardiographic markers can play a role in the prevention and 
treatment of cardiac dysrhythmias. According to our results changes 
in T-wave-peak-to-end interval and AIX occurred only in the case of 
hemodialysis which reflects an increased susceptibility of ventricular 
repolarization and an altered disposition to ventricular arrhythmias. 
However, malignant ventricular arrhythmias were not observed 
in any one of the modalities applied, ventricular premature beats 
appeared significantly more often during hemodialysis. Regarding 
arrhythmogenic index and the ratio of ventricular premature beats a 
positive correlation occurred only in the case of hemodialysis. These 
findings indicate the increased risk of ventricular dysrhythmias in 
the case of conventional hemodialysis. The possible reasons for the 
differences with regard to electrocardiographic parameters observed 
between the two modalities even at the beginning of treatments have 
not been clearly understood yet. Interestingly, left ventricular mass 
and electrocardiographic markers showed a significant relationship 
only in the case of hemodialysis, which may represent the increased 
arrhythmogenic potential of conventional therapy in patients with 
ventricular hypertrophy. The relationship between the left ventricular 
systolic dysfunction and the tendency to ventricular arrhythmias has 
been confirmed also in the case of hemodialysis. However a negative 
tendency between systolic function and electrocardiographic markers 
was found also during hemodiafiltration, which did not reach the level of 
significance. Thus, it can be concluded that left ventricular dysfunction 
seems to have a more definitive effect on ventricular repolarization 
in the case of hemodialysis compared to the convective treatment. 
Both left atrial cross diameter and the diameter of the inferior vena 
cava measured at the beginning of the sessions appeared to correlate 
significantly only in the case of hemodialysis. This phenomenon 
attracts the attention to the importance of the alteration between the 
dynamicity of volume removal during renal replacement therapies; 
also it could be the result of the differences between the intravascular 
and intracardiac dynamics of the volume state between the two 
renal replacement modalities. Importantly, no significant difference 
appeared between the total volume removal between hemodialysis and 
hemodiafiltration. Also, the increase in ventricular frequency, observed 
only during hemodialysis suggests a variation in intravascular volume 
changes between hemodialysis and hemodiafiltration. A degree of 
similarity between the total volume removals might be indicated by the 
kinetics in the changes of blood pressure. The possible reasons for the 
significant differences observed between the two modalities even at the 
beginning of treatments have not been clearly established and require 
further investigations. Changes in serum sodium concentration proved 
to significantly correlate with T-wave-peak-to-end interval only in 
the case of hemodialysis, therefore, the favourable effects seen during 
hemodiafiltration could also be the consequence of a more efficiently 
balanced sodium concentration and the smoother, but more efficient 
changes in osmotic conditions and volume depletion. Another plausible 
explanation is the potent antioxidant and anti-inflammatory effect, and 
also the more efficient removal of the small-and medium-molecular-
weight materials and uremic toxins that could be observed during 
hemodiafiltration. Importantly, drug therapy remained unchanged 
in the whole investigation time interval. Therefore, we conclude that 
the described differences between the two modalities were certainly 
not caused by drug therapies. According to our results we conclude 
that hemodiafiltration has a disparate effect on the studied arrhythmia 
markers of the surface electrocardiogram compared to hemodialysis. 
These clinical investigations were performed on an appropriate 
professional standard. We applied adequate technical methods to 
determine electrocardiographic, echocardiographic and laboratory 
parameters. The level of significance and the statistical power of our 
data were supported by appropriately chosen statistical tests. 
The number of the studied patients was relatively small in our 
study, however all patients suitable for clinical investigations were 
enrolled from our centre. Further clinical examinations involving a 
larger study population may help to clarify the role of different renal 
replacement therapies on ventricular arrhythmogeneity in the future. 
The determination of long term effects of hemodiafiltration on cardiac 
arrhythmias was not possible during the present study, therefore 
further investigations are needed to get a clearer picture on this issue. 
Our results apply only to our selected group of patients with a low 
frequency of coronary artery disease.
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